Lunetta, M <br/><br/>
Effects of octreotide on glycaemic control, glucose disposal, hepatic glucose production and counterregulatory hormones secretion in type 1 and type 2 insulin treated diabetic patients.  [electronic resource] 

 -  Diabetes research and clinical practice  Nov 1997 
 - 81-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0168-8227 
<br/><br/><label>Standard No.: </label>10.1016/s0168-8227(97)00094-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Agents, Hormonal--administration & dosage<br/>C-Peptide--drug effects<br/>Diabetes Mellitus--drug therapy<br/>Diabetes Mellitus, Type 1--drug therapy<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Female<br/>Glucose--metabolism<br/>Hormones--blood<br/>Humans<br/>Hyperglycemia--drug therapy<br/>Hypoglycemic Agents--therapeutic use<br/>Injections, Subcutaneous<br/>Insulin--therapeutic use<br/>Liver--metabolism<br/>Male<br/>Middle Aged<br/>Octreotide--administration & dosage